A 60-year-old obese woman (BMI 38 kg/m²) with T2DM (HbA1c 69 mmol/mol) is on metformin 2 g daily and empagliflozin 25 mg. eGFR is 75 mL/min/1.73m².

Question

A 60-year-old obese woman (BMI 38 kg/m²) with T2DM (HbA1c 69 mmol/mol) is on metformin 2 g daily and empagliflozin 25 mg. eGFR is 75 mL/min/1.73m². She has had a prior MI. Her priority is weight reduction. What is the most appropriate additional agent?

Accepted Answer

GLP-1 receptor agonist (semaglutide)

Answer

Insulin glargine

Answer

Sulfonylurea (gliclazide)

Answer

DPP-4 inhibitor (sitagliptin)

Answer

SGLT2 inhibitor (empagliflozin)

Type 2 Diabetes with Obesity — RACP Adult Medicine MCQ

A 60-year-old obese woman (BMI 38 kg/m²) with T2DM (HbA1c 69 mmol/mol) is on metformin 2 g daily and empagliflozin 25 mg. eGFR is 75 mL/min/1.73m². She has had a prior MI. Her priority is weight reduction. What is the most appropriate additional agent?